Navigation Links
2 federal public health grants awarded to Weill Cornell Medical College
Date:1/16/2008

NEW YORK (Jan. 16, 2008) -- Two major federal grants have been awarded to Public Health faculty at Weill Cornell Medical College in New York City.

Dr. Kenneth W. Griffin is the recipient of a three-year $1.6 million NIH grant from the National Institute on Drug Abuse (NIDA) for research into the long-term effects of a school-based drug-abuse prevention program previously delivered to urban minority youth attending New York City middle schools. The study will focus on a sample of approximately 3,500 young adults, ages 21 to 23, who participated in a randomized prevention trial during their early teens. In addition to testing the long-term effects of the prevention program on alcohol, tobacco and illicit drug use among the participants as young adults, the study will test whether the effects generalize to a variety of sexual risk behaviors.

Dr. Griffin is associate professor of public health in the Division of Prevention and Health Behavior, Department of Public Health, Weill Cornell Medical College.

Dr. Inmaculada de Melo-Martn is the recipient of a two-year $150,000 National Science Foundation Grant (NSF) for innovative research examining the ways in which the concept of human dignity is used in current debates about contentious biotechnologies such as embryonic stem cell research, human genetic enhancement and the creation of human-nonhuman chimeras. It will provide the first systematic assessment of what several influential scholars and recent national and international science policy documents mean when they say that these technologies threaten human dignity. Thus, the research can play a role in improving dialogue between the sciences and the humanities, and between the sciences and society.

Dr. de Melo-Martn is associate professor of public health in the Division of Medical Ethics, Department of Public Health, Weill Cornell Medical College.

"These awards represent important acknowledgments of the societal value of Dr. Griffin's and Dr. de Melo-Martn's work," says Dr. Alvin I. Mushlin, the Nanette Laitman Professor and Chairman of the Department of Public Health at Weill Cornell. "They are also examples of the diversity in public health research being conducted in the Department."


'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Related biology news :

1. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
2. NOAA proposes federal regulations to protect black abalone
3. How the public perceives biotech
4. Anthony S. Fauci awarded Lasker Award for Public Service
5. Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study
6. BIO-key International Showcasing Innovative Public Safety Solutions at 2007 IACP Conference
7. Mandate for public access to NIH-funded research poised to become law
8. Market testing of dietary supplements and drugs underscores value of USPs public health programs
9. Asthma link to post-traumatic stress disorder, says Mailman School of Public Health study
10. Columbia researchers: Growth of CT scan use may lead to significant public health problem
11. Wireless Public Safety Solution From BIO-key(R) and DaProSystems Links Virginia Law Enforcement Agencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... -- Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the ... latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers ... The result of a collaboration among several companies with expertise in toolholding, cutting ...
Breaking Biology Technology: